In addition, the pharmacology from the Lively factors was largely uncharacterized, and affirmation of SCB use was hindered by a lack of recognized biomarkers. These information gaps prompted experts across numerous disciplines to swiftly (1) monitor, establish and quantify with chromatography/mass spectrometry the at any time-transforming contents